Home

ROBERT LIPTAK

CIK 1252523 · last filed 2019-02-11

ROBERT LIPTAK is a corporate insider who has filed 15 SEC Form 4 insider transactions across 4 companies since 2010. The most recent filing, for GMED, was dated Feb 11, 2019. Across all open-market trades the lifetime net is −$205.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.55M

Companies

4

Total Filings

15

Lifetime Open-Market Net

-$205.32M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GMED Director 41,159 $86.25 $3.55M -$9.88M 12 2019-02-11
AERIE PHARMACEUTICALS INC (AERI) Delisted 10%+ Owner 3,529,093 $15.25 $53.82M -$21.83M 1 2014-12-30
ZOGENIX, INC. (ZGNX) Delisted 10%+ Owner 9,482,439 $26.68 $252.99M $63.00M 1 2011-09-20
AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted 10%+ Owner 9,646,520 — — -$236.61M 1 2010-11-02

Recent Filings

15 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-02-11 GMED Grant (A) — $0 EDGAR
2018-01-24 GMED Grant (A) — $0 EDGAR
2017-02-01 GMED Grant (A) — $0 EDGAR
2016-01-27 GMED Grant (A) — $0 EDGAR
2016-01-06 GMED Mixed — -$186.0K EDGAR
2015-01-22 GMED Grant (A) — $0 EDGAR
2014-12-30 AERIE PHARMACEUTICALS INC (AERI) Delisted Sell (S) −726,516 -$21.83M EDGAR
2014-01-27 GMED Grant (A) — $0 EDGAR
2013-12-10 GMED Sell (S) −25,000 -$484.0K EDGAR
2013-09-05 GMED Other (J) −7,193,042 $0 EDGAR
Showing 1–10 of 15
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.